1. Cleland JGF, Daubert J-C, Erdmann E, Freemantle N, Gras D, Kappenberger L et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. The New England Journal of Medicine. 2005;352(15):1539–49. DOI: 10.1056/NEJMoa050496
2. Fornwalt BK, Sprague WW, BeDell P, Suever JD, Gerritse B, Merlino JD et al. Agreement Is Poor Among Current Criteria Used to Define Response to Cardiac Resynchronization Therapy. Circulation. 2010;121(18):1985–91. DOI: 10.1161/CIRCULATIONAHA.109.910778
3. Wikstrom G, Blomstrom-Lundqvist C, Andren B, Lonnerholm S, Blomstrom P, Freemantle N et al. The effects of aetiology on outcome in patients treated with cardiac resynchronization therapy in the CARE-HF trial. European Heart Journal. 2008;30(7):782–8. DOI: 10.1093/eurheartj/ehn577
4. Dhesi S, Lockwood E, Sandhu RK. Troubleshooting Cardiac Resynchronization Therapy in Nonresponders. Canadian Journal of Cardiology. 2017;33(8):1060–5. DOI: 10.1016/j.cjca.2017.04.007
5. Zareba W, Klein H, Cygankiewicz I, Hall WJ, McNitt S, Brown M et al. Effectiveness of cardiac resynchronization therapy by QRS morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Circulation. 2011;123(10):1061–72. DOI: 10.1161/CIRCULATIONAHA.110.960898
6. Gold MR, Thébault C, Linde C, Abraham WT, Gerritse B, Ghio S et al. Effect of QRS Duration and Morphology on Cardiac Resynchronization Therapy Outcomes in Mild Heart Failure: Results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) Study. Circulation. 2012;126(7):822–9. DOI: 10.1161/CIRCULATIONAHA.112.097709
7. Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). European Heart Journal. 2013;34(29):2281– 329. DOI: 10.1093/eurheartj/eht150
8. Мареев В.Ю., Фомин И.В., Агеев Ф.Т., Беграмбекова Ю.Л., Васюк Ю.А., Гарганеева А.А. и др. Клинические рекомендации ОССН – РКО – РНМОТ. Сердечная недостаточность: хроническая (ХСН) и острая декомпенсированная (ОДСН). Диагностика, профилактика и лечение. Кардиология. 2018;58(6S):8-164. DOI: 10.18087/cardio.2475
9. Cleland JG, Abraham WT, Linde C, Gold MR, Young JB, Claude Daubert J et al. An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure. European Heart Journal. 2013;34(46):3547–56. DOI: 10.1093/eurheartj/eht290
10. Kang S-H, Oh I-Y, Kang D-Y, Cha M-J, Cho Y, Choi E-K et al. Cardiac resynchronization therapy and QRS uration: systematic review, meta-analysis, and meta-regression. Journal of Korean Medical Science. 2015;30(1):24–33. DOI: 10.3346/jkms.2015.30.1.24
11. Кузнецов В.А., Солдатова А.М., Малишевский Л.М. Использование параметров комплекса QRS электрокардиограммы при отборе пациентов на сердечную ресинхронизирующую терапию. Вестник аритмологии. 2017;87:42-8
12. Surawicz B, Childers R, Deal BJ, Gettes LS. AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. Journal of the American College of Cardiology. 2009;53(11):976–81. DOI: 10.1016/j.jacc.2008.12.013
13. Aranda JM, Conti JB, Johnson JW, Petersen-Stejskal S, Curtis AB. Cardiac resynchronization therapy in patients with heart failure and conduction abnormalities other than left bundle-branch block: analysis of the Multicenter InSync Randomized Clinical Evaluation (MIRACLE). Clinical Cardiology. 2004;27(12):678–82. DOI: 10.1002/clc.4960271204
14. Gervais R, Leclercq C, Shankar A, Jacobs S, Eiskjaer H, Johannessen A et al. Surface electrocardiogram to predict outcome in candidates for cardiac resynchronization therapy: a sub-analysis of the CARE-HF trial. European Journal of Heart Failure. 2009;11(7):699–705. DOI: 10.1093/eurjhf/hfp074
15. Birnie DH, Ha A, Higginson L, Sidhu K, Green M, Philippon F et al. Impact of QRS morphology and duration on outcomes after cardiac resynchronization therapy: results from the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial (RAFT). Circulation: Heart Failure. 2013;6(6):1190–8. DOI: 10.1161/CIRCHEARTFAILURE.113.000380
16. Кузнецов В.А., Колунин Г.В., Харац В.Е., Криночкин Д.В., Рычков А.Ю., Горбунова Т.Ю. и др. Регистр проведенных операций сердечной ресинхронизирующей терапии. Свидетельство о государственной регистрации базы данных № 2010620077 от 1 февраля 2010 года
17. Yu C-M, Chau E, Sanderson JE, Fan K, Tang M-O, Fung W-H et al. Tissue Doppler Echocardiographic Evidence of Reverse Remodeling and Improved Synchronicity by Simultaneously Delaying Regional Contraction After Biventricular Pacing Therapy in Heart Failure. Circulation. 2002;105(4):438–45. DOI: 10.1161/hc0402.102623
18. The ESC textbook of cardiovascular medicine. Camm AJ, Lüscher TF, Serruys PW, European Society of Cardiology, editors -Malden, Mass.; Oxford: Blackwell Pub./European Society of Cardiology;2006. - 1122 p. ISBN 978-1-4051-2695-3
19. Strauss DG, Selvester RH, Wagner GS. Defining Left Bundle Branch Block in the Era of Cardiac Resynchronization Therapy. The American Journal of Cardiology. 2011;107(6):927–34. DOI: 10.1016/j.amjcard.2010.11.010
20. Almer J, Zusterzeel R, Strauss DG, Trägårdh E, Maynard C, Wagner GS et al. Prevalence of manual Strauss LBBB criteria in patients diagnosed with the automated Glasgow LBBB criteria. Journal of Electrocardiology. 2015;48(4):558–64. DOI: 10.1016/j.jelectrocard.2015.01.008
21. Clark EN, Katibi I, Macfarlane PW. Automatic detection of end QRS notching or slurring. Journal of Electrocardiology. 2014;47(2):151–4. DOI: 10.1016/j.jelectrocard.2013.10.007
22. McHugh ML. Interrater reliability: the kappa statistic. Biochemia Medica. 2012;22(3):276–82. PMID: 23092060
23. Cleland JGF, Mareev Y, Linde C. Reflections on EchoCRT: sound guidance on QRS duration and morphology for CRT? European Heart Journal. 2015;36(30):1948–51. DOI: 10.1093/eurheartj/ehv264
24. van Deursen CJM, Blaauw Y, Witjens MI, Debie L, Wecke L, Crijns HJGM et al. The value of the 12-lead ECG for evaluation and optimization of cardiac resynchronization therapy in daily clinical practice. Journal of Electrocardiology. 2014;47(2):202–11. DOI: 10.1016/j.jelectrocard.2014.01.007
25. van Stipdonk AMW, Hoogland R, ter Horst I, Kloosterman M, Vanbelle S, Crijns HJGM et al. Evaluating Electrocardiography-Based Identification of Cardiac Resynchronization Therapy Responders Beyond Current Left Bundle Branch Block Definitions. JACC: Clinical Electrophysiology. 2020;6(2):193–203. DOI: 10.1016/j.jacep.2019.10.009
26. Caputo ML, van Stipdonk A, Illner A, D’Ambrosio G, Regoli F, Conte G et al. The definition of left bundle branch block influences the response to cardiac resynchronization therapy. International Journal of Cardiology. 2018;269:165–9. DOI: 10.1016/j.ijcard.2018.07.060
27. Уцумуева М.Д., Миронова Н.А., Каштанова С.Ю., Стукалова О.В. Возможности магнитнорезонансной томографии сердца при отборе кандидатов на сердечную ресинхронизирующую терапию. Медицинская визуализация. 2018;22(4):20-31. DOI: 10.24835/1607-0763-2018-4-20-31
28. Лебедев Д.И., Попов С.В., Мишкина А.И., Лебедева М.В. Влияние сократительной функции миокарда правого желудочка на эффективность проводимой сердечной ресинхронизирующей терапии. Кардиология. 2018;58(S2):19-24. DOI: 10.18087/cardio.2436
29. Mascioli G, Padeletti L, Sassone B, Zecchin M, Lucca E, Sacchi S et al. Electrocardiographic criteria of true left bundle branch block: a simple sign to predict a better clinical and instrumental response to CRT. Pacing and clinical electrophysiology. 2012;35(8):927–34. DOI: 10.1111/j.1540-8159.2012.03427.x
30. Jastrzębski M, Kukla P, Kisiel R, Fijorek K, Moskal P, Czarnecka D. Comparison of four LBBB definitions for predicting mortality in patients receiving cardiac resynchronization therapy. Annals of Noninvasive Electrocardiology. 2018;23(5):e12563. DOI: 10.1111/anec.12563
31. Kisiel R, Fijorek K, Moskal P, Kukla P, Pavlinec C, Stec J et al. True left bundle branch block and long-term mortality in cardiac resynchronisation therapy patients. Kardiologia Polska. 2019;77(3):371–9. DOI: 10.5603/KP.a2019.0032
32. Galeotti L, van Dam PM, Loring Z, Chan D, Strauss DG. Evaluating strict and conventional left bundle branch block criteria using electrocardiographic simulations. Europace. 2013;15(12):1816–21. DOI: 10.1093/europace/eut132
33. Van Stipdonk AMW, Vanbelle S, ter Horst IAH, Luermans JG, Meine M, Maass AH et al. Large variability in clinical judgement and definitions of left bundle branch block to identify candidates for cardiac resynchronisation therapy. International Journal of Cardiology. 2019;286:61–5. DOI: 10.1016/j.ijcard.2019.01.051